HIMS
Hims & Hers Health, Inc.
stock NYSE

I will be the newest long term investor of HIMS once these 16.5 CSP cover.
Need some of those 37% short float boys to bail me out with a little squeeze. 🥺

HIMS stock was already well over $20 on their existing business of ED and hair loss treatment before they started into the GLP1 compounding business stream. That (and rampant speculation!) catapulted them up into the $70s.
I’m expecting them to bounce back into the $20s with good results, albeit with the legal threat hanging over the company.
Has always been a company with excessive volatility - the CEO (Palestinian married to a Jew) made public comments supporting US students who were anti-genocide. These whipped the zionists into a frenzy and it’s been a fairground ride ever since.

HIMS as a value question: what is the core worth if GLP1 goes to near zero

Rivian has replaced HIMS.

can't even afford HIMS now 😤

HIMS: FDA letter + patent suit + reported DOJ referral

HIMS: FDA letter + patent suit + reported DOJ referral

HIMS: FDA letter + Patent suit + reported DOJ referral

HIMS

HIMS bounce

This is the last “dip” that I’m going to be able to buy now, I have no more bullets.
Maybe I should go to HIMS/HERS and get a pill for this

Triple dog dare you to fulport this account into HIMS at 9:30 a.m. February 23rd!!!!
Who is with me on this?

What's the new play you're eyeing for the wheel now that you've rotated out of HIMS?

No point in presenting facts or reasoning with people who still own $HIMS theyre all delusional and out of touch with reality 

Went to HIMS for Viagra prescription vs waiting 2 months to see my primary DR and you’re bearish?

Short HIMS $ MARA. Free lunch money

[HIMS](https://www.onvista.de/aktien/HIMS-HERS-HEALTH-Aktie-US4330001060) - Hims & Hers Health 📃@13.46€(+0,64% 🥱)

Einen wunderschönen guten Morgen außer an die $HIMS Taschenhalter

Point 1, Novonordisk suing Hims & Hers: https://www.reuters.com/legal/litigation/novo-nordisk-opens-new-front-with-patent-suit-over-hims-wegovy-copies-2026-02-10/?utm_source=perplexity
Correction to Point 2 (thank you @sandiegoshea): HIMS $3.59b, NVO $218.29. When NVO market cap is googled, the value given is in Danish Kronr which I overlooked.
Point 3: a company with 60x the market cap of the other will win in a lawsuit when they both operate in a capital intensive industry like drug production. This was inferred, but considering the dominant legal position Novo hold as the owners of the patent (see source for Point 1), I struggle to see a way out for HIMS other than through a sizeable settlement
Additional point 4: US courts are very different to British/European ones. Lots of fingers in lots of pies, lots of capitalism going up against even more capitalism, the end result is that unless you can compete on funding, you’re screwed. US legal teams still bill old school I.e. 20 hour billable days…

I bailed on HIMS in December. This was a 1.5-3% overall hit. But I was up in total 40% for the year. Can’t win them all!